Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics
Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a U.S.-based CRDMO serving the biotechnology community with development and production services, have established a strategic partnership.
LakePharma Inc., a U.S.-based biologics contract research, development and manufacturing organization (CRDMO), and New Brunswick-based NJ Biopharmaceuticals LLC, a contract research organization (CRO) providing integrated chemistry and biology services, announced on Tuesday the formation of a strategic alliance to offer streamlined antibody-drug conjugate (ADC) development solutions for the biotechnology and pharmaceutical sectors.
Californian life sciences companies Twist Bioscience and LakePharma have penned a new pact designed to offer antibody discovery services to biopharma clients.
SAN FRANCISCO & SAN CARLOS, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and LakePharma, Inc., the leading US-based biologics CRDMO, today announced a strategic collaboration to offer antibody discovery and development solutions to pharmaceutical and biotechnology customers.
The California company once rumored to be an anchor tenant at the Worcester Biomanufacturing Park is now fully operational at a facility in Hopkinton.